Drugs / NDBR 105
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00584454 | Feb 2006 → Jul 2009 | Q fever | U.S. Army Medical Research and Development Command | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NDBR 105 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00584454 ↗ |
| Modality | Vaccine | “Q Fever Vaccine, Phase I, Inactivated, Freeze-Dried, NDBR 105” NCT00584454 ↗ |
| Route | Subcutaneous | “may be vaccinated with Q Fever Vaccine, Phase I, Inactivated, Freeze-Dried, NDBR 105 (subcutaneously, 0.5 ml)” NCT00584454 ↗ |